NCT00445874

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Vistakon Pharmaceuticals · Industry
• Sex: All
• Age: 8 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis

Conditions

• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	Ketotifen with a Contact Lens (no generic name)

Timeline

• Start date: 2007-02-01
• Completion: 2007-05-01
• First posted: 2007-03-09
• Last updated: 2009-04-09

Locations

7 sites across 1 country: United States